Atlas Trials

UPMC OPTIMISE-C19 Trial, a COVID-19 Study

Clinical trial NCT04790786 · TERMINATED

Trial details

NCT number
NCT04790786
Sponsor
Erin McCreary
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Covid19
Start date
2021-03-10
Primary completion
2022-06-16
Enrollment
4571

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.